Fennec teams with Tampa General Hospital for PEDMARK study Mar 4, 2026 07:06AM
Fennec presents real world data on PEDMARK for head and neck cancer patients Feb 20, 2026 07:03AM
B.Riley Starts Fennec Pharmaceuticals Inc. (FENC) at Buy Feb 12, 2026 02:26AM
Piper Sandler Starts Fennec Pharmaceuticals Inc. (FENC) at Overweight Jan 9, 2026 12:58AM
City of Hope to test PEDMARK for hearing loss prevention in testicular cancer Dec 9, 2025 07:02AM


Dec 2, 2025 07:02AM Fennec reports positive Japan trial results for PEDMARK hearing loss drug
Nov 19, 2025 07:03AM Fennec Pharmaceuticals completes full debt redemption
Nov 13, 2025 06:45PM Fennec Pharmaceuticals (FENC) Misses Q3 EPS by 9c
Aug 14, 2025 03:13PM Fennec Pharmaceuticals Inc. (FENC) PT Raised to $14 at Craig-Hallum
Aug 14, 2025 06:08AM Fennec Pharmaceuticals (FENC) Misses Q2 EPS by 7c
Jun 3, 2025 04:31PM Fennec Pharmaceuticals (FENC) announces voting results from AGM
May 13, 2025 06:04AM Fennec Pharmaceuticals (FENC) Tops Q1 EPS by 6c
Mar 11, 2025 06:51AM H.C. Wainwright Reiterates Buy Rating on Fennec Pharmaceuticals Inc. (FENC)
Mar 10, 2025 06:13AM Fennec Pharmaceuticals (FENC) Tops Q4 EPS by 7c
Feb 7, 2025 07:00AM Fennec Pharmaceuticals (FENC) Announces Commercial Launch of PEDMARQSI In Germany
Dec 20, 2024 06:16AM Fennec Pharmaceuticals (FENC) Reports Pedmarqsi Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales
Dec 19, 2024 06:14AM Fennec Pharmaceuticals (FENC) Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management
Nov 7, 2024 06:13AM Fennec Pharmaceuticals (FENC) Misses Q3 EPS by 11c
Aug 22, 2024 06:33AM Fennec Pharmaceuticals Inc. (FENC) PT Lowered to $13 at H.C. Wainwright
Aug 13, 2024 06:06AM Fennec Pharmaceuticals (FENC) Misses Q2 EPS by 18c
Aug 5, 2024 06:27AM Jeffrey S. Hackman Appointed as CEO and Director at Fennec Pharmaceuticals (FENC)
Jul 1, 2024 06:03AM Fennec Pharmaceuticals (FENC) Announces Management Change